Namenda Isn't End Of NY AG's Pharma Work: Antitrust Chief
The New York attorney general's antitrust chief told Law360 Friday that the enforcer would stay active in the pharmaceutical product-hopping arena in the wake of the Second Circuit's recent ruling against...To view the full article, register now.
Already a subscriber? Click here to view full article